Category: Podcast

Interoperability in healthcare 2019: Podcast interview with Rhapsody

published date
March 19th, 2019 by

image001

Interoperability has a been a buzzword in healthcare for about a decade, but sometimes it doesn’t seem like we’ve gotten that far. In this podcast, Rhapsody’s EVP of Product & Strategy, Drew Ivan and I discuss interoperability: its past, present and future.

Here’s what we covered:

  • 0:20 What is interoperability anyway?
  • 2:50 Why do we hear about interoperability so much in healthcare? Is it an issues in other industries?
  • 5:11 How does interoperability in the US compare to the situation elsewhere?
  • 6:51 Does interoperability matter to patients?
  • 9:20 Has interoperability failed in the past? What new models are being tried?
  • 11:54 What’s the business model for interoperability?
  • 13:42 Are there any downsides? Does interoperability create any new problems?
  • 14:54 How will interoperability evolve in the coming year?

By healthcare business consultant David E. Williams, president of Health Business Group.

#CareTalk February 2019: Medicare for All?

published date
February 28th, 2019 by

The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I explore Medicare for All and other big topics.

Here’s what we covered:

(0:35) Is “Medicare for All” quickly becoming a litmus test for Democratic presidential candidates?

(2:45) What should be made of the recent moves of home health agencies around primary care?

(5:00) Are pharma rebates to blame for increased drug pricing?

(8:00) President Trump promised a whopping $50 million a year for childhood cancer. What would you do with all that money?

(8:32) Will adding the full list price of drugs in ads make a difference?

(9:03) Will Donald Trump actually end HIV transmission by 2030?

(9:32) We predicted that the Patriots would win the championship this year. What about the other Boston sports teams?

Subscribe to the #CareTalk Podcast
iTunes: https://apple.co/2DIDTcr
Google Play: https://bit.ly/2RobqMB

Agenus plans digital security offering. PCG’s Jeff Ramson explains in this podcast

published date
February 25th, 2019 by

agenus logo

Biotech company Agenus is launching a “digital security offering” that will let people invest directly in a single biotech product, rather than the whole company. Jeff Ramson, founder and CEO of strategic communications firm PCG Advisory Group, became fascinated by the concept and reached out to me to discuss it, even though he is not involved in the offering. (And neither am I.)

In this podcast, we cover the following topics:

  1. Agenus is launching the first asset-backed digital security offering in healthcare. What does it mean?
  2. What is a Biotech Electronic Security Token (BEST)? What are the trends it leverages?
  3. How is it being used?
  4. Has something like this already been used in other industries?
  5. What are the advantages? How does it preserve shareholder equity?
  6. Any disadvantages?
  7. Why not a traditional stock offering?
  8. What is PCG Advisory Group and what is your role?

By healthcare business consultant David E. Williams, president of Health Business Group.

#CareTalk November 2018: Bipartisan breakthroughs in health policy

published date
November 30th, 2018 by

The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I dig into the healthcare impact of the recent election.

Here’s what we covered:

  • (0:32) What are your keys takeaways for healthcare coming out of the 2018 mid-term elections?
  • (3:09) Medicare Advantage plans can offer supplemental benefits in 2019. Is this a big deal?
  • (6:22) The Trump Administration wants to tie some US drug prices to foreign benchmarks. Is this a serious proposal?
  • (8:17) Are you surprised to see the FDA clamp down so strongly on vaping?

Lightning round

  • (10:29) Did you talk about healthcare at the Thanksgiving table?
  • (10:57) Will the Supreme Court overturn Roe v Wade?
  • (11:30) How are you liking your new Apple Watch?
  • (12:01) How about them Red Sox?

By healthcare business consultant David E. Williams, president of Health Business Group.

Social network for cancer patients: Interview with Belong’s CTO Irad Deutsch

published date
October 2nd, 2018 by
Irad Deutsch
Irad Deutsch

Belong.life bills itself as the largest social network for cancer patients and caregivers. With over 100,000 participants, Belong is approaching the scale at which it can generate meaningful insights, and leverage machine learning and artificial intelligence to create a “hyper-personalized” experience.

I spoke recently with Irad Deutsch, Chief Technology Officer. He described how his personal experience as a caregiver led him to co-found the company, and talked about what makes Belong valuable and differentiated.

Overview:

  • (0:12) What are some of the main unmet needs for cancer patients and caregivers? Why was there a need for Belong in the first place?
  • (2:15) What, specifically does Belong do for patients that they can’t get elsewhere?
  • (4:23) How are providers and payers involved with Belong? Is this mainly a branding and cost-saving tool for them?
  • (7:03) What about pharmaceutical companies?
  • (8:00) You recently released a cancer fatigue survey. Why did you conduct that and what did it show? Any real surprises?
  • (10:08) You talk a lot about big data and machine learning but it’s not readily evident how those play in to Belong. Can you explain?
  • (12:50 What is the company’s business model?

By healthcare business consultant David E. Williams, president of Health Business Group.